论文部分内容阅读
新生儿缺氧缺血性脑病(HIE)是由围生期缺氧导致的颅脑损伤,是新生儿死亡和婴幼儿神经系统功能障碍的主要原因[1]。因此,对HIE合理、有效的治疗是当前研究的热点之一。我院新生儿重症监护室(NICU)2007年3月—2010年5月收治HIE患儿86例,其中应用神经节苷脂(GM-1)辅助治疗42例,取得了较好疗效,并做了随访观察,现总结报告如下。
Neonatal hypoxic-ischemic encephalopathy (HIE) is a brain injury caused by perinatal hypoxia and is a major cause of neonatal death and neurological dysfunctions in infants and young children [1]. Therefore, a reasonable and effective treatment of HIE is one of the hot spots in current research. Neonatal Intensive Care Unit (NICU) in our hospital from March 2007 to May 2010 86 cases of HIE admitted to children, including ganglioside (GM-1) adjuvant treatment of 42 cases, and achieved good results, and do Follow-up observation, the report is summarized as follows.